Conduct of the Research Collaboration. The Research Collaboration shall be conducted at Institute under the supervision of the Principal Investigator and commenced promptly after the Original Effective Date. Institute shall use Commercially Reasonable Efforts to conduct the Autologous Programs, and the Parties shall use Commercially Reasonable Efforts to conduct the Allogeneic Programs, in accordance with all applicable laws, rules and regulations, the terms and conditions of this Agreement, the Development Plan attached as [Schedule 2.2] and incorporated by reference herein, and in the case of the Allogeneic Programs under the supervision of the JSC. Institute will furnish the facilities, know-how, and technical skills necessary for performance of the Research Collaboration. Anything in this Agreement to the contrary notwithstanding, Atara and Institute may at any time modify the scope of the Research Collaboration, including the Development Plan, by mutual written agreement in a document executed by duly authorized representatives of both Parties or otherwise expressly agreed to in writing by the Alliance Managers and representatives on the JSC of both Parties that states that it is effectuating such a modification.

Conduct of Research and Development. HFB and its Affiliates have conducted all Development of Licensed Compound and Option Compound in accordance with all Applicable Law.

Conduct of the Research Collaboration. The Research Collaboration shall be conducted at Institute under the supervision of the Principal Investigator and commenced promptly after the Original Effective Date. Institute shall use Commercially Reasonable Efforts to conduct the Autologous Programs, and the Parties shall use Commercially Reasonable Efforts to conduct the Allogeneic Programs, in accordance with all applicable laws, rules and regulations, the terms and conditions of this Agreement, the Development Plan attached as [Schedule 2.2] and incorporated by reference herein, and in the case of the Allogeneic Programs under the supervision of the JSC. Institute will furnish the facilities, know-how, and ​= Certain confidential information contained in this document, marked by brackets, is omitted because it is both # not material and # would be competitively harmful if publicly disclosed.

Research. Subject to the terms and conditions of this Agreement, Xenon hereby grants to Neurocrine a non-exclusive, non-royalty bearing license with the right to grant sublicenses through multiple tiers as set forth in Section 2.3, under the Xenon Licensed IP to research Excluded Compounds in the Field in the Territory.

Research. During the Collaborative Period, [[Senomyx:Organization]] will collaborate with [[Firmenich:Organization]] in the Collaborative Program on an Exclusive basis in the Field.

Conduct. Each Party shall use Commercially Reasonable Efforts to perform and fulfill its respective activities under this Agreement, and shall do so in accordance with Applicable Law, including GCP, GLP and GMP.

Conduct. Notwithstanding anything in this Agreement to the contrary, Supplier acknowledges that the Properties are operated as cemeteries, funeral homes and/or related uses and that Supplier and its employees, affiliates, invitees, licensees, agents, consultants, contractors and subcontractors (collectively, the “Supplier Parties”) shall conduct themselves with an appropriate level of decorum when entering, working on, and leaving the Properties. Supplier and the Supplier Parties shall perform all Services in a manner that does not unreasonably disrupt, interfere with or disturb the conduct of Customer’s business or the use or enjoyment of the Properties by Customer, or its invitees, licensees or permittees.

Conduct. Each Party shall use Commercially Reasonable Efforts to # perform and fulfill its respective activities under the Combined Therapy Clinical Trial and this Agreement on a timely basis and in an effective manner consistent with prevailing standards, # supply the quantities of its Study Drug in accordance with [Article 4] as needed to conduct the Combined Therapy Clinical Trial on a timely basis, and, in the case of the Recipient, package and deliver same to study sites on a timely basis, and # in the case of the Recipient, conduct and complete the Combined Therapy Clinical Trial on a timely basis in accordance with the Protocol and Third Party agreements relating thereto, and provide sufficient resources, funding and personnel to conduct and perform the Combined Therapy Clinical Trial on a timely basis in accordance with the Protocol for same and the terms of this Agreement. Each Party shall perform its duties for the Combined Therapy Clinical Trial in accordance with Applicable Law, including GCP, GLP and GMP as applicable.

Conduct. Each Party shall use Commercially Reasonable Efforts to perform and fulfill its respective Development activities under this Agreement, including all remaining pre-clinical and clinical testing necessary or useful for Developing the Product and the preparation and submission of the appropriate Regulatory Documentation required for the Commercialization of the Products in the Field in the Territory, and each Party shall do so in accordance with Applicable Law.

Rights to Assume Conduct of Aduro Research Activities. Lilly will have the right, upon written notice to Aduro no later than ​ days from the date that Lilly receives such notice of the closing or effectiveness of such Competing Acquisition, to take over the conduct of all, or a designated portion (at Lilly’s sole discretion) of the remaining Aduro Research Activities, outside the authority of the JRC, at Lilly’s own cost and expense. Notwithstanding Lilly taking over such activities, it shall remain responsible for all milestones and royalties with respect to Products as provided for in this Agreement, Aduro shall have no liability for any performance of the Aduro Research Activities by or on behalf of Lilly, and all other terms and conditions of this Agreement remain in full force and effect.